BACKGROUND: Many individuals with hepatitis C virus (HCV) infection are undiagnosed. PURPOSE: This study describes the development and the use and outcomes of a mass media campaign, combined with an Internet risk assessment and an Internet-mediated blood-testing procedure for HCV to identify individuals infected with HCV in the general population. METHODS: From April 2007 to December 2008, individuals in HCV risk groups were referred to an online, previously validated risk-assessment questionnaire at www.heptest.nl. Individuals at risk could download a referral letter for a free, anonymous HCV blood test in a nonclinical setting. Test results could be obtained online, 1 week later, using a personal log-in code. Anti-HCV-positive participants were requested to visit the Public Health Service for confirmation and RNA testing. Chronically HCV-infected individuals were referred for treatment. Data were analyzed in 2009-2010. RESULTS: The website attracted 40,902 visitors. Of the 9653 who completed the questionnaire, 2553 were at risk for HCV (26.4%). Main reported risk factors were a blood transfusion prior to 1992 and noninjecting drug use. Of the 1480 eligible for the blood test, 420 opted for testing (28%). HCV antibodies were detected in 3.6% (n=15, 95% CI=2.1%, 5.7%); of the 12 with a chronic HCV infection, six began treatment. CONCLUSIONS: Internet-mediated risk-based testing for HCV has proved to be a feasible and effective strategy to identify undiagnosed HCV infection in the general population. All HCV-infected individuals belonged to hard-to-reach populations. Test uptake was 28%, which is high for an online project that includes blood testing. Because Internet-mediated testing is low-cost, this strategy holds promise for future screening.
BACKGROUND: Many individuals with hepatitis C virus (HCV) infection are undiagnosed. PURPOSE: This study describes the development and the use and outcomes of a mass media campaign, combined with an Internet risk assessment and an Internet-mediated blood-testing procedure for HCV to identify individuals infected with HCV in the general population. METHODS: From April 2007 to December 2008, individuals in HCV risk groups were referred to an online, previously validated risk-assessment questionnaire at www.heptest.nl. Individuals at risk could download a referral letter for a free, anonymous HCV blood test in a nonclinical setting. Test results could be obtained online, 1 week later, using a personal log-in code. Anti-HCV-positive participants were requested to visit the Public Health Service for confirmation and RNA testing. Chronically HCV-infected individuals were referred for treatment. Data were analyzed in 2009-2010. RESULTS: The website attracted 40,902 visitors. Of the 9653 who completed the questionnaire, 2553 were at risk for HCV (26.4%). Main reported risk factors were a blood transfusion prior to 1992 and noninjecting drug use. Of the 1480 eligible for the blood test, 420 opted for testing (28%). HCV antibodies were detected in 3.6% (n=15, 95% CI=2.1%, 5.7%); of the 12 with a chronic HCV infection, six began treatment. CONCLUSIONS: Internet-mediated risk-based testing for HCV has proved to be a feasible and effective strategy to identify undiagnosed HCV infection in the general population. All HCV-infected individuals belonged to hard-to-reach populations. Test uptake was 28%, which is high for an online project that includes blood testing. Because Internet-mediated testing is low-cost, this strategy holds promise for future screening.
Authors: Jeanne Heil; Christian J P A Hoebe; Jochen W L Cals; Henriëtte L G Ter Waarbeek; Inge H M van Loo; Nicole H T M Dukers-Muijrers Journal: Ann Fam Med Date: 2018-01 Impact factor: 5.166
Authors: Angelique P A Vermeiren; Nicole H T M Dukers-Muijrers; Inge H M van Loo; Frans Stals; Dirk W van Dam; Ton Ambergen; Christian J P A Hoebe Journal: PLoS One Date: 2012-12-07 Impact factor: 3.240
Authors: Anouk T Urbanus; Anneke van den Hoek; Albert Boonstra; Robin van Houdt; Lotte J de Bruijn; Titia Heijman; Roel A Coutinho; Maria Prins Journal: PLoS One Date: 2011-09-14 Impact factor: 3.240
Authors: Freke R Zuure; Titia Heijman; Anouk T Urbanus; Maria Prins; Gerjo Kok; Udi Davidovich Journal: BMC Public Health Date: 2011-05-10 Impact factor: 3.295
Authors: Anouk T Urbanus; Marjolijn van Keep; Amy A Matser; Mark H Rozenbaum; Christine J Weegink; Anneke van den Hoek; Maria Prins; Maarten J Postma Journal: PLoS One Date: 2013-08-12 Impact factor: 3.240
Authors: Joseph D Tucker; Kathrine Meyers; John Best; Karyn Kaplan; Razia Pendse; Kevin A Fenton; Isabelle Andrieux-Meyer; Carmen Figueroa; Pedro Goicochea; Charles Gore; Azumi Ishizaki; Giten Khwairakpam; Veronica Miller; Antons Mozalevskis; Michael Ninburg; Ponsiano Ocama; Rosanna Peeling; Nick Walsh; Massimo G Colombo; Philippa Easterbrook Journal: BMC Infect Dis Date: 2017-11-01 Impact factor: 3.090
Authors: Lauren M K Mason; Irene K Veldhuijzen; Erika Duffell; Ayla van Ahee; Eveline M Bunge; Andrew J Amato-Gauci; Lara Tavoschi Journal: J Viral Hepat Date: 2019-08-16 Impact factor: 3.728